CoChat

Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility

Open access
Wang, Jun-Qin, Qi, Rui-Rui, Zhou, Wei, Tang, Yi-Fan, Pan, Lei-Lei, Cai, Yi-Ling · 2015 · PLOS ONE

The DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To identify differentially expressed genes associated with motion sickness (MS) susceptibility in the rat caudal vestibular nucleus. METHODS: We identified MS susceptible (MSS) and insusceptible (inMSS) rats by quantifying rotation-induced MS symptoms: defecation and spontaneous locomotion activity. Microarray analysis was used to screen differentially expressed genes in the caudal vestibular nucleus (CVN) after rotation. Plasma stress hormones were identified by radioimmunoassay. Candidate genes were selected by bioinformatics analysis and the microarray results were verified by real-time quantitative-PCR (RT-qPCR) methods. By using Elvax implantation, receptor antagonists or recombinant adenovirus targeting the candidate genes were applied to the CVN to evaluate their contribution to MS susceptibility variability. Validity of gene expression manipulation was verified by RT-qPCR and western blot analysis. RESULTS: A total of 304 transcripts were differentially expressed in the MSS group compared with the inMSS group. RT-qPCR analysis verified the expression pattern of candidate genes, including nicotinic cholinergic receptor (nAchR) α3 subunit, 5-hydroxytryptamine receptor 4 (5-HT4R), tachykinin neurokinin-1 (NK1R), γ-aminobutyric acid A receptor (GABAAR) α6 subunit, olfactory receptor 81 (Olr81) and homology 2 domain-containing transforming protein 1 (Shc1). In MSS animals, the nAchR antagonist mecamylamine significantly alleviated rotation-induced MS symptoms and the plasma β-endorphin response. The NK1R antagonist CP99994 and Olr81 knock-down were effective for the defecation response, while the 5-HT4R antagonist RS39604 and Shc1 over-expression showed no therapeutic effect. In inMSS animals, rotation-induced changes in spontaneous locomotion activity and the plasma β-endorphin level occurred in the presence of the GABAAR antagonist gabazine. CONCLUSION: Our findings suggested that the variability of the CVN gene expression profile after motion stimulation might be a putative molecular basis for individual differences in MS susceptibility and provide information for the development of new therapeutic strategies for MSS individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0124203

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Data analysis for the defecation response and total distance traveled for MS susceptibility evaluation in microarray experiment. (A) Linear relationship between the number of fecal granules and total distance traveled in the Rot and Sta group (n = 34 in each group). The distribution of the number of fecal granules (B) and total distance traveled (C) in staic control (n = 34), MSS-Rot (n = 5), inMSS-Rot (n = 6), and other rotated animals (n = 23).
Fig 1 Data analysis for the defecation response and total distance traveled for MS susceptibility evaluation in microarray experiment. (A) Linear relationship between the number of fecal granules and total distance traveled in the Rot and Sta group (n = 34 in each group). The distribution of the number of fecal granules (B) and total distance traveled (C) in staic control (n = 34), MSS-Rot (n = 5), inMSS-Rot (n = 6), and other rotated animals (n = 23).CC BY · PubMed Central
Fig 2 Elvax preparation and CVN tissue sampling. (A) Illustration for Elvax sheet preparation and (B) photograph of a rat brain stem showing the location of Elvax sheet implantation. (C) Representative Nissl-staining image showing the CVN sampling region. 4V: fourth ventricle; MVe: medial vestibular nucleus; SpVe: spinal vestibular nucleus; NTS: nucleus of solitary tract; Pr: prepositus nucleus; X: nucleus X; Bar: 200 μm.
Fig 2 Elvax preparation and CVN tissue sampling. (A) Illustration for Elvax sheet preparation and (B) photograph of a rat brain stem showing the location of Elvax sheet implantation. (C) Representative Nissl-staining image showing the CVN sampling region. 4V: fourth ventricle; MVe: medial vestibular nucleus; SpVe: spinal vestibular nucleus; NTS: nucleus of solitary tract; Pr: prepositus nucleus; X: nucleus X; Bar: 200 μm.CC BY · PubMed Central
Fig 3 Hierarchical clustering of the signal value and signaling regulatory network of the differentially expressed genes. (A)Heat map of differential changes in gene expression between MSS-Rot and inMSS-Rot animals. The dendrogram was produced by hierarchical clustering of the signal value of differentially expressed genes in MSS-Rot rats (n = 4, left) and inMSS-Rot samples (n = 5, right). Colorimetric scaling of standardized gene expression values ranging from low (green) to high (red) is shown in the legend (upper left). (B) Signal-net of the differentially expressed genes. Red nodes and blue nodes represent up-regulated and down-regulated genes, respectively. Grey nodes represent intermediate genes functionally connecting the differentially expressed genes. Solid lines with arrow head indicate activation (a), dotted lines indicate inhibition (inh) and solid lines indicate binding (b) or expression regulation (ex). Node size represents the degrees of diiference in gene expression levels of MSS relative to inMSS.
Fig 3 Hierarchical clustering of the signal value and signaling regulatory network of the differentially expressed genes. (A)Heat map of differential changes in gene expression between MSS-Rot and inMSS-Rot animals. The dendrogram was produced by hierarchical clustering of the signal value of differentially expressed genes in MSS-Rot rats (n = 4, left) and inMSS-Rot samples (n = 5, right). Colorimetric scaling of standardized gene expression values ranging from low (green) to high (red) is shown in the legend (upper left). (B) Signal-net of the differentially expressed genes. Red nodes and blue nodes represent up-regulated and down-regulated genes, respectively. Grey nodes represent intermediate genes functionally connecting the differentially expressed genes. Solid lines with arrow head indicate activation (a), dotted lines indicate inhibition (inh) and solid lines indicate binding (b) or expression regulation (ex). Node size represents the degrees of diiference in gene expression levels of MSS relative to inMSS.CC BY · PubMed Central
Fig 4 RT-qPCR verification of candidate genes mRNA levels, including the nAchR α3 subunit, 5-HT4R, NK1R, the GABAAR α6 subunit, Olr81 and Shc1 in the CVN of MSS and inMSS rats receiving 2 hours of rotation or static treatment. Values in each group (n = 6) are expressed as the percentage of their corresponding GAPDH values (100%) and shown as the means (±S.E.). *P<0.05, compared with inMSS-Rot group; ΔP<0.05, compared with MSS-Sta group; † P<0.05 compared with inMSS-Sta group.
Fig 4 RT-qPCR verification of candidate genes mRNA levels, including the nAchR α3 subunit, 5-HT4R, NK1R, the GABAAR α6 subunit, Olr81 and Shc1 in the CVN of MSS and inMSS rats receiving 2 hours of rotation or static treatment. Values in each group (n = 6) are expressed as the percentage of their corresponding GAPDH values (100%) and shown as the means (±S.E.). *P<0.05, compared with inMSS-Rot group; ΔP<0.05, compared with MSS-Sta group; † P<0.05 compared with inMSS-Sta group.CC BY · PubMed Central
Fig 5 Effects of Elvax implantation over the CVN on the defecation response induced by rotation stimulation. In MSS animals, Elvax was loaded with solvent (Sham); 1.25 or 2.50 mM mecamylamine (Me); 5.00 or 10.00 mM RS39604 (RS); 5.00 or 10.00 mM CP99994 (CP); 3.50×107 or 7.00 ×107 GFU/ml pAd-shOlr81 (shOlr81); or 3.35 ×108 or 6.70 ×108 GFU/ml pAd-Shc1 (Shc1) at final concentration/titer (n = 5 in each group). In inMSS animals, Elvax was loaded with solvent (Sham) or gabazine (Ga) to a final concentration of 0.25 or 0.5 mM (n = 5 in each group). All data presented are expressed as the means and the vertical bars represent SEM. Statistical significance: **P<0.01, * P<0.05 compared with the rotation-induced defecation response before Elvax implantation.
Fig 5 Effects of Elvax implantation over the CVN on the defecation response induced by rotation stimulation. In MSS animals, Elvax was loaded with solvent (Sham); 1.25 or 2.50 mM mecamylamine (Me); 5.00 or 10.00 mM RS39604 (RS); 5.00 or 10.00 mM CP99994 (CP); 3.50×107 or 7.00 ×107 GFU/ml pAd-shOlr81 (shOlr81); or 3.35 ×108 or 6.70 ×108 GFU/ml pAd-Shc1 (Shc1) at final concentration/titer (n = 5 in each group). In inMSS animals, Elvax was loaded with solvent (Sham) or gabazine (Ga) to a final concentration of 0.25 or 0.5 mM (n = 5 in each group). All data presented are expressed as the means and the vertical bars represent SEM. Statistical significance: **P<0.01, * P<0.05 compared with the rotation-induced defecation response before Elvax implantation.CC BY · PubMed Central
Fig 6 Effects of Elvax implantation over the CVN on spontaneous locomotion activity after rotation stimulation. (A) Total distance travelled; (B) Immobile duration; (C) Body center-point moving duration. The final concentration of mecamylamine (Me), RS39604 (RS, CP99994 (CP) and gabazine (Ga) and the final titer of pAd-shOlr81 (shOlr81) and pAd-Shc1 (Shc1) in Elvax, and the number of animals used in each treatment group are the same as those in Fig 5. All data presented are expressed as the means and the vertical bars represent SEM. * P<0.05 compared with rotation-induced spontaneous locomotion activity response before the Elvax implantation.
Fig 6 Effects of Elvax implantation over the CVN on spontaneous locomotion activity after rotation stimulation. (A) Total distance travelled; (B) Immobile duration; (C) Body center-point moving duration. The final concentration of mecamylamine (Me), RS39604 (RS, CP99994 (CP) and gabazine (Ga) and the final titer of pAd-shOlr81 (shOlr81) and pAd-Shc1 (Shc1) in Elvax, and the number of animals used in each treatment group are the same as those in Fig 5. All data presented are expressed as the means and the vertical bars represent SEM. * P<0.05 compared with rotation-induced spontaneous locomotion activity response before the Elvax implantation.CC BY · PubMed Central
Fig 7 Effects of Elvax implantation over the CVN on plasma β-endorphin level after rotation stimulation. The final concentration of mecamylamine (Me), RS39604 (RS, CP99994 (CP) and gabazine (Ga) and the final titer of pAd-shOlr81 (shOlr81) and pAd-Shc1 (Shc1) in Elvax, and the number of animals used in each treatment group are the same as those in Fig 5. All data presented were expressed as the mean and vertical bars represent SEM. * P<0.05 compared with sham control group.
Fig 7 Effects of Elvax implantation over the CVN on plasma β-endorphin level after rotation stimulation. The final concentration of mecamylamine (Me), RS39604 (RS, CP99994 (CP) and gabazine (Ga) and the final titer of pAd-shOlr81 (shOlr81) and pAd-Shc1 (Shc1) in Elvax, and the number of animals used in each treatment group are the same as those in Fig 5. All data presented were expressed as the mean and vertical bars represent SEM. * P<0.05 compared with sham control group.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 90 references

Cited by

See all 11

Metadata

Authors
Wang, J.-Q., Qi, R.-R., Zhou, W., Tang, Y.-F., Pan, L.-L., & Cai, Y.-L.
Affiliations
Second Military Medical University (CN)
Venue
PLOS ONE
Published
2015-04-24
Volume
10
Issue
4
Pages
e0124203
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1985913723
Cited by
11
References
91
Citations by year
2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 1
FWCI
1.24
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Natural Science Foundation of Shanghai (12ZR1437300)
  • National Natural Science Foundation of China (81272178)
  • Nanjing University
Topics
  • Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
  • Health Sciences › Medicine › Surgery › Nausea and vomiting management
  • Health Sciences › Medicine › Physiology (medical) › Spaceflight effects on biology
Keywords
motion sickness, differential gene expression, 5-HT4 receptor, tachykinin NK1 receptor, SHC1, mecamylamine, gabazine, beta-endorphin, vestibular system
MeSH terms
Animals, Behavior, Animal, Disease Models, Animal, Gene Expression Regulation, Hormones, Locomotion, Male, Motion Sickness, Vestibular Nuclei, Reproducibility of Results, Cluster Analysis, Genetic Predisposition to Disease, Rats, Gene Regulatory Networks, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility. https://app.cochat.ai/papers/10.1371/journal.pone.0124203
The paper
Wang, J.-Q., Qi, R.-R., Zhou, W., Tang, Y.-F., Pan, L.-L., & Cai, Y.-L. (2015). Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility. PLOS ONE. https://doi.org/10.1371/journal.pone.0124203

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.